These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21533380)

  • 1. Optimal duration of whole body hyperthermia when combined with cis-diamminedichloroplatinum(II).
    Makino M; Ohno S; Sakaguchi Y; Kaneko T; Strebel F; Jenkins G; Bull J
    Int J Oncol; 1997 Feb; 10(2):329-32. PubMed ID: 21533380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin).
    Kaneko T; Sakaguchi Y; Makino M; Matsuda H; Strebel FR; Jenkins GN; Bull JM
    Anticancer Res; 1997; 17(3C):1897-901. PubMed ID: 9216642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
    Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
    Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of altered duration of 41.5 degrees C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats.
    Toyota N; Strebel FR; Stephens LC; Rowe W; Matsuda H; Oshiro T; Jenkins GN; Bull JM
    Oncol Rep; 1998; 5(5):1231-6. PubMed ID: 9683841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
    Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
    Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
    Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
    Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
    Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
    Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.
    Sakaguchi Y; Makino M; Kaneko T; Stephens LC; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
    Cancer Res; 1994 Apr; 54(8):2223-7. PubMed ID: 8174130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma.
    Toyota N; Strebel FR; Stephens LC; Matsuda H; Oshiro T; Jenkins GN; Bull JM
    Int J Cancer; 1998 May; 76(4):499-505. PubMed ID: 9590125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
    Wondergem J; Bulger RE; Strebel FR; Newman RA; Travis EL; Stephens LC; Bull JM
    Cancer Res; 1988 Jan; 48(2):440-6. PubMed ID: 3335012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA
    Int J Hyperthermia; 1991; 7(6):893-903. PubMed ID: 1806643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs.
    Page RL; Thrall DE; George SL; Price GS; Heidner GL; McEntee MC; Novotney CA; Hauck ML; Dewhirst MW
    Int J Hyperthermia; 1992; 8(6):761-9. PubMed ID: 1479202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.
    Sakaguchi Y; Stephens LC; Makino M; Kaneko T; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
    Cancer Res; 1995 Nov; 55(22):5459-64. PubMed ID: 7585616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(II) on nonirradiated and preirradiated rat solid tumors.
    van Bree C; Rietbroek RC; Schopman EM; Kipp JB; Bakker PJ
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):135-40. PubMed ID: 8823268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-duration, mild whole body hyperthermia with cisplatin: tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma.
    Toyota N; Strebel FR; Stephens LC; Matsuda H; Bull JM
    Int J Hyperthermia; 1997; 13(5):497-506. PubMed ID: 9354934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?
    Wondergem J; Siddik ZH; Strebel FR; Bull JM
    Eur J Cancer; 1993; 29A(4):549-54. PubMed ID: 8435209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of [cis-diaminedichloroplatinum(ii) hyperthermia] therapy by inhibitors of arachidonic-Acid metabolism.
    Teicher B; Holden S; Herman T; Northey D
    Int J Oncol; 1994 Jan; 4(1):17-22. PubMed ID: 21566883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA
    Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
    Herman TS; Teicher BA; Cathcart KN; Kaufmann ME; Lee JB; Lee MH
    Cancer Res; 1988 Sep; 48(18):5101-5. PubMed ID: 3409235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.